Updated

Medtronic raised its financial outlook for a second time, citing continued strong demand for its heart devices. The upgrade reflects sustained growth in the company's cardiovascular product lines and adds to a string of positive guidance revisions from the medical device maker. Investors viewed the announcement as a sign of resilient demand within the medical technology sector despite broader economic uncertainty.